v3.25.4
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Number of Common Shares Reserved for Issuance
The number of common shares reserved for issuance under the 2019 Plan are as follows: 
(in millions)December 31,
20252024
Shares available for granting 1
17.918.0
Options outstanding——
Total shares reserved for issuance17.918.0
1 Shares reserved for issuance under the Director Plan are less than 1.0 million at both December 31, 2025 and 2024.
Schedule of Stock-based Compensation Expense
Stock-based compensation expense and the corresponding tax benefit are as follows: 
(in millions)Year Ended December 31,
 202520242023
Restricted stock and other stock-based awards expense$236 $247 $171 
Stock option expense — — — 
Total stock-based compensation expense$236 $247 $171 
Tax benefit$43 $49 $32 
Schedule of Restricted Stock and Unit Activity
Restricted stock and other stock-based award activity is as follows: 
(in millions, except per award amounts)SharesWeighted-average grant-date fair value
Balance as of December 31, 2024
1.2 $387.14 
Granted 0.4 $525.67 
Vested(0.4)$392.96 
Forfeited(0.3)$404.59 
Balance as of December 31, 2025
0.9 $436.46 
Total unrecognized compensation expense related to restricted awards$173 
Weighted-average years to be recognized over1.2

 Year Ended December 31,
 202520242023
Weighted-average grant-date fair value per award$525.67 $427.84 $374.00 
Total fair value of restricted stock and other stock-based awards vested$222 $230 $323 
Tax benefit relating to restricted award activity$60 $56 $71 
Schedule of Stock Option Activity
Stock option activity is as follows:
(in millions, except per award amounts)SharesWeighted average exercise priceWeighted-average remaining years of contractual termAggregate intrinsic value
Options outstanding as of December 31, 2024
— $74.46 
Options outstanding as of December 31, 2025
— $74.46 1.22$5 
Options exercisable as of December 31, 2025
— $74.46 1.22$5 
1 There are less than 0.1 million options outstanding and exercisable.
Schedule of Stock Option Exercises
Information regarding our stock option exercises is as follows: 
(in millions)Year Ended December 31,
 202520242023
Net cash proceeds from the exercise of stock options$— $4 $13 
Total intrinsic value of stock option exercises$— $19 $55 
Income tax benefit realized from stock option exercises$— $5 $12